AEON Biopharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -20 | |||
EBITDA | -6,080 | -2,511 | -4,302 | -3,931 |
EBIT | -6,100 | -2,530 | -4,322 | -3,950 |
Net Income | -37,137 | -4,538 | -6,642 | 9,095 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,712 | -2,596 | -2,091 | -7,913 |
Cash | 3,006 | 5,927 | 8,439 | 10,446 |
Basic Shares | 12,105 | 11,634 | 11,090 | 3,984 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -78 | ||
EBITDA | -16,824 | -27,727 | -48,361 |
EBIT | -16,902 | -27,824 | -48,429 |
Net Income | -39,222 | 42,005 | -52,556 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -17,312 | -20,292 | -35,890 |
Cash | 3,006 | 13 | 9,746 |
Basic Shares | 9,921 | 575 | 1,928 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.24 |
2025-12-31 | -$3.72 |
2025-09-30 | -$0.39 |
2025-06-30 | -$0.60 |